Rhythm Pharmaceuticals RYTM
NASDAQ RYTM
$95.21 -0.50 (-0.52%)
At close: Sep 30, 2026 · 4:00 PM EDT

Rhythm Pharmaceuticals (RYTM) Other Non-Current Assets (2016 - 2026)

Updated

Rhythm Pharmaceuticals (RYTM) posted Other Non-Current Assets of $603,000 for Q2 2026, up 14.4% from $527,000 a year earlier and up 0.3% from the prior quarter.

Analysis

Rhythm Pharmaceuticals (RYTM) Other Non-Current Assets (2016 - 2026) Analysis & Trends

At the end of FY2025, Rhythm Pharmaceuticals' Other Non-Current Assets came in at $522,000, up 12.5% from FY2024.

  • Annual Other Non-Current Assets shows a five-year compound annual growth rate of 5.3% (FY2020 to FY2025).
  • In prior years, Rhythm Pharmaceuticals' Other Non-Current Assets was $464,000 in FY2024 (+41.5%), $328,000 in FY2023 (unchanged), $328,000 in FY2022 (unchanged) and $328,000 in FY2021 (-18.6%).
  • Quarterly Other Non-Current Assets has run from a low of $328,000 in Q3 2021 to a high of $671,000 in Q3 2025 over five years.
  • On a year-over-year basis, Other Non-Current Assets has increased in each of the last ten quarters, with growth averaging 24.9% over the last eight quarters.
  • The strongest year-over-year quarter for Other Non-Current Assets in the past five years was Q3 2025, with growth of 45.2%; the weakest was Q3 2021, with a decline of 18.6%.
  • According to Business Quant data, Other Non-Current Assets for the three prior quarters was $601,000 (Q1 2026), $522,000 (Q4 2025) and $671,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 14.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.73 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 4.75 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 Rhythm Pharmaceuticals 6.55 Bn 5.42 Bn 62.32 Mn 603,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 603,000.00
Mar 31, 2026 601,000.00
Dec 31, 2025 522,000.00
Sep 30, 2025 671,000.00
Jun 30, 2025 527,000.00
Mar 31, 2025 464,000.00
Dec 31, 2024 464,000.00
Sep 30, 2024 462,000.00
Jun 30, 2024 460,000.00
Mar 31, 2024 460,000.00
Dec 31, 2023 328,000.00
Sep 30, 2023 328,000.00
Jun 30, 2023 328,000.00
Mar 31, 2023 328,000.00
Dec 31, 2022 328,000.00
Sep 30, 2022 328,000.00
Jun 30, 2022 328,000.00
Mar 31, 2022 328,000.00
Dec 31, 2021 328,000.00
Sep 30, 2021 328,000.00
API Access

Rhythm Pharmaceuticals Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=RYTM&period=max&api_key=YOUR_API_KEY